NEUROONE MEDICAL TECHNOLOGIES Corp·4

Jan 5, 2:41 PM ET

McClurg Ronald W. 4

4 · NEUROONE MEDICAL TECHNOLOGIES Corp · Filed Jan 5, 2021

Insider Transaction Report

Form 4
Period: 2021-01-01
McClurg Ronald W.
Chief Financial Officer
Transactions
  • Award

    Option to Purchase Common Stock

    2021-01-01+180,000180,000 total
    Exercise: $1.57Exp: 2031-01-01Common Stock (180,000 underlying)
Footnotes (1)
  • [F1]25% will vest on January 1, 2022 and the remaining 75% will vest in 36 equal monthly installments beginning on February 1, 2022.

Documents

1 file
  • 4
    ownership.xmlPrimary